TICKVALE
>⌘K
NYSE · CIK 0001555280 · PHARMACEUTICAL PREPARATIONS

Zoetis Inc.

ZTS chart by TradingView
P/E 11.4xP/B 9.5xP/SALES 3.2xEV/EBITDA FCF YIELD 7.72%

PRICE HISTORY

LIVE · NYSE
ZTS chart by TradingView
REVENUE FY2025 ENDED DEC 2025
$9.5B
EBITDA
FREE CASH FLOW
$2.3B
EPS
$6.02
GROSS MARGIN
71.84%
ROIC
26.71%
Q2 FY26ENDED JUN 2026HOVERDRAG ACROSS ANY CHART TO SCRUB ALL 24 · 40 QUARTERS SHOWNVALUATIONGROWTHPROFITABILITY & RETURNSCASH & CAPITALBALANCE SHEET

VALUATION

what you pay for a unit of the business7 CHARTS

P / E RATIO (TTM)

11.4x
-70%
LATEST · Q2 FY26
11.4xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
11.4x57.1x

P / SALES (TTM)

3.2x
-41%
LATEST · Q2 FY26
3.2xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
3.2x14.9x

P / BOOK

9.5x
-42%
LATEST · Q2 FY26
9.5xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
9.5x25.6x

EV / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EV / REVENUE (TTM)

3.9x
-35%
LATEST · Q2 FY26
3.9xQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
3.9x15.3x

FCF YIELD (TTM)

7.72%
+5.9pp
LATEST · Q2 FY26
7.72%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
1.49%7.72%

DIVIDEND YIELD (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

GROWTH

is the business getting bigger5 CHARTS

REVENUE

$2.5B
+99%
LATEST · Q2 FY26
2.5BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EBITDA (DERIVED)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

NET INCOME

$0.7B
+189%
LATEST · Q2 FY26
0.7BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

EPS (DILUTED)

$1.65
+245%
LATEST · Q2 FY26
1.65Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

REVENUE GROWTH YOY

-0.24%
-2.5pp
LATEST · Q2 FY26
-0.24%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
-0.24%25.84%

PROFITABILITY & RETURNS

what survives to the bottom, and what it earns on capital4 CHARTS

FCF MARGIN

21.80%
+7.1pp
LATEST · Q2 FY26
21.80%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
0.78%35.96%

RETURN ON CAPITAL

24.60%
+11.8pp
LATEST · Q2 FY26
24.60%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
12.76%26.71%

RETURN ON EQUITY (TTM)

83.77%
+40.3pp
LATEST · Q2 FY26
83.77%Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26
42.36%83.77%

MARGIN FUNNEL

every line is a share of the same revenue, so they read on one scale — the gaps are what each layer takes out, and net rises above operating when income arrives from outside the business
GROSS MARGIN72.73%
OPERATING MARGIN
NET MARGIN28.00%
FCF MARGIN21.80%
80.4860.3640.2420.120.00GROSSNETFCFQ3 FY16Q3 FY17Q3 FY18Q3 FY19Q3 FY20Q3 FY21Q3 FY22Q3 FY23Q3 FY24Q3 FY25Q2 FY26

CASH & CAPITAL

where the money actually goes5 CHARTS

FREE CASH FLOW

$0.5B
+196%
LATEST · Q2 FY26
0.5BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

STOCK-BASED COMP

$0.0B
+189%
LATEST · Q2 FY26
0.0BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

CAPITAL EXPENDITURE

$0.1B
+105%
LATEST · Q2 FY26
0.1BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

SHARES OUTSTANDING

0.42B
-16%
LATEST · Q2 FY26
0.42BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DIVIDEND / SHARE

$0.53
+$0.53
LATEST · Q2 FY26
0.53Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

BALANCE SHEET

how much cushion there is3 CHARTS

CASH & EQUIVALENTS

$1.5B
+127%
LATEST · Q2 FY26
1.5BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

TOTAL DEBT

$9.0B
+103%
LATEST · Q2 FY26
9.0BQ3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

DEBT / EBITDA (TTM)

LATEST · Q2 FY26
Q3 FY16Q3 FY18Q3 FY20Q3 FY22Q3 FY24Q2 FY26

OWNERSHIP

10 LARGEST HOLDERS · WHO OWNS THE FLOAT
INSTITUTIONS 102.83%INSIDERS 0.15%OTHER / RETAIL 0.00%2,117 INSTITUTIONAL FILERS
HOLDER% HELDSHARESVALUECHANGE
Blackrock Inc.8.49%35.6M$2.59B-4.7%
Vanguard Capital Management LLC6.22%26.1M$1.89BNEW
Vanguard Portfolio Management LLC5.72%24.0M$1.74BNEW
State Street Corporation4.61%19.3M$1.40B-2.4%
State Farm Mutual Automobile Insurance Co3.79%15.9M$1.15B+0.0%
Morgan Stanley3.37%14.1M$1.03B-8.5%
Geode Capital Management, LLC2.71%11.3M$824.6M+0.2%
Wellington Management Group, LLP2.42%10.2M$737.5M-10.9%
Nordea Investment Management AB1.57%6.6M$479.0M+12.4%
Northern Trust Corporation1.32%5.5M$403.0M-3.5%
AS OF 2026-03-31 · MOST RECENT 13F FILINGS
SOURCE → 10-K · 10-Q · 8-K / GUIDANCE · ALL FILINGS
FILING DATA AS OF 2026-08-10. Figures are derived from public SEC EDGAR filings (40most recent quarters shown, Q4 implied as full-year minus Q1-Q3). Valuation multiples use each period’s fiscal period-end close. Live price charts and quotes are provided by TradingView. This page is informational only — it is not investment advice, and figures are not warranted for accuracy. EBITDA is not a GAAP measure; it is derived as operating income + D&A. Verify against the linked source filing before relying on any number here.